PharmaSource: The External Manufacturing Community 11 Outsourcing Leader tickets left Apply for your pass Days Hours Minutes Essential intelligence for biopharma outsourcing leaders | Trusted by 50,000+ professionals | Subscribe TOP STORIES Kindeva Adds Second PFS Filler Line at Missouri Fill-Finish Facility Read More » Medisca Expands North American API Access Through EUROAPI Partnership Marvel Biosciences Signs LOI With Novotech CRO for Phase 1 First-in-Human Trial of MB-204 in Australia Olon Expands ADC Platform With New Biologics Capacity in France Terumo Launches K-Pack Embrace Active Safety Needle Globally ACG Introduces RecycloPod PP Ultra With Moisture and Oxygen Barriers Charles River Laboratories Launches Apollo Orchestrate for Digital GMP Testing Quantum BioPharma Signs Phase 2 Study Start-Up Agreement With Thermo Fisher’s PPD CRO for First-in-Class MS Candidate Lucid-MS Upperton Unveils New Brand Identity for End-to-End CDMO Ofichem to Acquire Kinentia Biosciences and Expand Into U.S. Market RoslinCT Receives Up to £7.25M Grant for Digital Manufacturing Expansion Piramal Pharma Solutions Adds Microbiology Capacity at Kentucky Sterile Facility Genezen Partners With InterAct Therapeutics on AAV8 Cancer Gene Therapy Curia Invests $28 Million in Sterile API Manufacturing MedPharm Signs Commercial Manufacturing Agreement With Global Pharmaceutical Company Catalent Launches 10-Month Gene-to-Drug Substance Program for Complex Biologics More news + insights Medisca Expands North American API Access Through EUROAPI Partnership Marvel Biosciences Signs LOI With Novotech CRO for Phase 1 First-in-Human Trial of MB-204 in Australia Olon Expands ADC Platform With New Biologics Capacity in France PODCASTS Container Closure Integrity: 6 Considerations for Evaluating CDMO Capabilities How to Select and Sustain an Early-Stage CDMO Partnership SPOTLIGHT Bridging Studies for AAV Producer Cell Line Adoption [Whitepaper] RESOURCES AI Pilots and Strategic Partnerships: ExM Leaders Basel 2026 Report Resilience, Risk & Relationships – ExM Leaders Report Bridging Studies for AAV Producer Cell Line Adoption [Whitepaper] UPCOMING EVENTS CDMO Live Americas . October 20-21, Boston 2026 MASTERCLASS: De-Risking Technology Transfer in OSD AI + Digital Maturity in Contract Manufacturing 2026 External Manufacturing Leaders Dublin 2026
Marvel Biosciences Signs LOI With Novotech CRO for Phase 1 First-in-Human Trial of MB-204 in Australia
Quantum BioPharma Signs Phase 2 Study Start-Up Agreement With Thermo Fisher’s PPD CRO for First-in-Class MS Candidate Lucid-MS
Marvel Biosciences Signs LOI With Novotech CRO for Phase 1 First-in-Human Trial of MB-204 in Australia